SCWorx Corp. (WORX)
- Previous Close
2.0300 - Open
2.0100 - Bid --
- Ask 2.5600 x 100
- Day's Range
1.9900 - 3.0000 - 52 Week Range
1.1400 - 14.4000 - Volume
576,583 - Avg. Volume
2,271,340 - Market Cap (intraday)
3.342M - Beta (5Y Monthly) 2.56
- PE Ratio (TTM)
-- - EPS (TTM)
-1.6500 - Earnings Date May 15, 2024 - May 22, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
SCWorx Corp. develops and markets health care information technology solutions and related services to improve healthcare processes and information flow within hospitals and other healthcare facilities in the United States. The company provides data content and services related to repair, normalization, and interoperability of information for healthcare providers, as well as big data analytics for the healthcare industry. It also offers virtualized item master file repair, expansion, and automation; electronic medical record management; charge description master management; contract management; request for proposal automation; rebate management; integration of acquired management; big data analytics modeling; data integration and warehousing; and ScanWorx. In addition, the company focuses on selling personal protective equipment and COVID-19 rapid test kits. It sells its solutions and services to hospitals and health systems through its direct sales force, and distribution and reseller partnerships. SCWorx Corp. is based in New York, New York.
www.scworx.com9
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: WORX
Performance Overview: WORX
Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: WORX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: WORX
Valuation Measures
Market Cap
3.34M
Enterprise Value
3.37M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.67
Price/Book (mrq)
0.54
Enterprise Value/Revenue
0.86
Enterprise Value/EBITDA
-1.73
Financial Highlights
Profitability and Income Statement
Profit Margin
-42.58%
Return on Assets (ttm)
-8.30%
Return on Equity (ttm)
-25.77%
Revenue (ttm)
3.92M
Net Income Avi to Common (ttm)
-1.67M
Diluted EPS (ttm)
-1.6500
Balance Sheet and Cash Flow
Total Cash (mrq)
72.43k
Total Debt/Equity (mrq)
7.76%
Levered Free Cash Flow (ttm)
-31.98k